Evidence map›Paper›PMID 29797257›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2018

Detection of Cross-Sample Contamination in Multiple Myeloma Samples and Sequencing Data.

Owen W Stephens, Tobias Meißner, Niels Weinhold

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Case report: 16-yr life history and genomic evolution of an ERCold Spring Harbor molecular case studies · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Owen W StephensThe Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Tobias MeißnerDepartment of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, USA.
Niels WeinholdThe Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. nweinhold@uams.edu.

Funding

Understanding the Negative Prognostic Impact of Intraosseous Focal Lesions in Multiple MyelomaP20GM125503 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Sanja Novak · 2018 to 2026
$23.0M
NIGMS NIH HHS P20 GM125503
6 · The paper itself

Abstract

The increasing applicability and sensitivity of next generation sequencing methods exacerbate one of the main issues in the molecular biology laboratory, namely cross-sample contamination. This type of contamination, which could massively increase the rate of false-positive calls in sequencing experiments, can originate at each step during the processing of multiple myeloma samples, such as CD138-selection of tumor cells, RNA and DNA isolation or the processing of sequencing libraries. Here we describe a Droplet Digital PCR (ddPCR) method and a simple bioinformatic solution for the detection of contamination in patient's samples and derived sequencing data, which are based on the same principle: detection of alternative alleles for single-nucleotide polymorphisms (SNPs) that are homozygous according to the control (germ line) sample.

Indexed as

DNA ContaminationSequence Analysis, DNAAllelesComputational BiologyGenotypeHumansMultiple MyelomaPolymerase Chain ReactionPolymorphism, Single NucleotideBioinformatics solutionCross-sample contaminationDroplet digital PCRMultiple myelomaSNP-based assay

Identifiers

PMID29797257
PMCPMC9481068

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.